
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
Keywords: SARS; SARS-CoV 3CL protease; Peptidomimetics; Dipeptide; Cysteine protease inhibitors; Docking study